1 Green Flag and 1 Red Flag For Inovio Pharmaceuticals
Developing innovative products is an excellent way for a company to become successful, and that's what Inovio Pharmaceuticals (NASDAQ: INO) is looking to do. Let's look at one reason Inovio could be an exciting contrarian buy, and one reason to stay away. Small-cap biotechs need promising pipeline programs to attract attention.